Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Abdomen Closure Technology Based on Component Separation: a Prospective Randomized Controlled Trial

NCT03111134 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.

NCT NCT03111134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03111134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Abdomen Closure Technology Based on Component Separation: a Prospective Randomized Controlled Trial
Lead sponsor
Xijing Hospital of Digestive Diseases
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2017
Completion date
December 31, 2018
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fascial closure